|
In This Issue |
|
Feature
Articles |
|
A resource that could be of immense value to the entire
sarcoma community
Editorial by Bruce
Shriver |
|
CTOS OP Ed: The Margin Matters: Someone's life depends
on it
Dr. Lor Randall discusses the
surgical margin. |
|
Targeted Therapies for Sarcomas: the next generation
of treatments
Dr. David Loeb reviews molecular,
ligand, passive and physiological targeted therapy. |
|
3,392 People Worldwide Demonstrate that "Sarcoma
Knows No Borders"
An update on the 2007 Team Sarcoma Initiative. |
|
The Genetic Information Nondiscrimination Act (GINA)
Orkideh Malkoc urges readers to support passage of
this act. |
|
Cancer Treatment Related Changes in
Cognitive Function (a.k.a. "Chemo Brain")
Denise Reinke discusses the phenomena
known as "chemo brain". |
|
First International Chordoma Research Workshop: summary
and outcomes
A workshop focused on
bringing
new basic-science researchers into the emerging chordoma research community. |
|
A Partial Index to Articles that have
Appeared in ESUN
We give an updated partial index to ESUN articles. |
|
Regular
Columns |
|
Clinical
Trial News
Tom Swartz
describes various
clinical trials.
 |
Currently Accepting Eligible Patients (not previously published in
ESUN) |
|
|
Not
Yet Recruiting Patients (not previously published in ESUN) |
|
|
Odds & Ends
Pointers
to resources and abstracts of
interesting articles. In this issue's
column:
|
|
Specialist Centers
Should Deal With All Soft Tissue Sarcomas
|
|
|
CTRC Enrolls First
Patients In Phase II Study; Living Virus Destroys Cancer Cells In Sarcoma
Patients |
|
|
Child Cancer
Patients Find Hope For Future Fertility |
|
|
Depression In Terminal
Illness: The Need For Primary Care-Specific Research
|
|
|
Knowledge of and Barriers
to Pain Management in Caregivers of Cancer Patients Receiving Homecare
|
|
|
Golfers Against Cancer Event Benefits
Osteosarcoma Research |
|
|
Sensitivity To Diverse Range Of
Chemotherapeutic Drugs Linked To Common Pathway
|
|
|
Guidelines for Identification of, Advocacy for, and
Intervention in Neurocognitive Problems in Survivors
of Childhood Cancer
|
|
|
Evaluation of Cognitive Function Associated With
Chemotherapy: A Review of Published Studies and
Recommendations for Future Research
|
|
|
Early Results Find Activity In Drug That Turns on Tumor "Death" Receptors
|
|
|
Positive
ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for
Medical Oncology |
|
|
Ariad Gets $75 Million Up Front In Merck Deal On mTOR Inhibitor
|
|
|
Spectrum Pharmaceuticals
Completes New Drug Application Filing for ISO-Vorin(TM)
|
|
|
At
Press Time |
|
|
Research Corner
Abstracts of recent sarcoma-related research articles. In this issue:
|
|
Heat Therapy Makes High-Risk Soft Tissue Sarcomas
More Treatable |
|
|
Randomized Phase
II Study of Gemcitabine and Docetaxel Compared With Gemcitabine
Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of
Sarcoma Alliance for Research Through Collaboration Study 002
|
|
|
Phase III Trial of
Two Investigational Schedules of Ifosfamide Compared With
Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue
Sarcoma: A European Organization for Research and Treatment of
Cancer Soft Tissue and Bone Sarcoma Group Study
|
|
|
Docetaxel: A
therapeutic option in the treatment of cutaneous angiosarcoma -
Report of 9 Patients |
|
|
Tumor
Angiogenesis: Cause or Consequence of Cancer?
|
|
|
Multifaceted
Dysregulation of the Epidermal Growth Factor Receptor Pathway in
Clear Cell Sarcoma of the Kidney
|
|
|
Efficacy of Trabectedin (ecteinascidin-743) in Advanced Pretreated
Myxoid Liposarcomas: A Retrospective Study
|
|
|
Delays in Cancer
Diagnosis in Underinsured Young Adults and Older Adolescents
|
|
|
Analysis of Genes
Critical for Growth Regulation Identifies Insulin-like Growth
Factor 2 Receptor Variations with Possible Functional
Significance as Risk Factors for Osteosarcoma
|
|
|
Gene Expression
Profiling of Liposarcoma
Identifies Distinct Biological Types/Subtypes and Potential
Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma
|
|
|
EWS/FLI1 Regulates
Tumor Angiogenesis in Ewing's
Sarcoma via Suppression of Thrombospondins
|
|
|
Trabectedin (ET-743): evaluation of its use in
advanced soft-tissue sarcoma
|
|
|
At Press Time
|
|
|
Stories of Courage and Hope
Tom Swartz abstracts several
inspiring stories we have recently encountered
about patients or
caregivers that tell of the strength that some are blessed
with in dealing with sarcoma. In this issue's column:
|
|
Dreams Do Come True
|
|
|
My Face
Nearly Killed Me |
|
|
Surviving To
Race |
|
|
Family,
Friends Help Keep Recovery On Track |
|
|
Michigan
Grad Remains Optimistic As He Fights Cancer
|
|
|
Miles Levin
receives SFA's Leadership in Courage Award |
|
|
Indie Musician's Fight
Ewing's Sarcoma |
|
|
Fall Fashion Show Makes
Fighting Cancer Chic |
|
|
Our Initiatives
Brief descriptions of some
of the Liddy Shriver Sarcoma Initiative projects are
presented. In this issue:
|
|
2008 Team
Sarcoma Initiative
|
|
|
The "Sarcoma Knows No Borders" Bracelet
|
|
|
Music CD,
The
Circle, Benefits Sarcoma Research
|
|
|
Guest Book
|
|
|
General
Information |
|
Disclaimer |
|
Medical Editorial Board and Editorial Staff |
|
Registering to
Receive Notifications About ESUN
Send
us a note containing your e-mail address if you would like
to receive a note when the next issue of
ESUN
is
published. |
|
Topics and Feedback
Please
send
us your recommendations for topics that you would like to
see covered in
ESUN as well as any other comments or
feedback that can be useful to us. We also welcome contributions
of essays and articles that are relevant to
ESUN and its intended audience |
